Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $1.62 and traded as high as $1.82. Evotec shares last traded at $1.7750, with a volume of 273,775 shares traded.
Evotec Price Performance
The company has a market capitalization of $586.14 million, a P/E ratio of 4.33 and a beta of 0.98. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The business’s 50-day moving average price is $1.62 and its 200 day moving average price is $2.49.
About Evotec
Evotec SE is a Germany-based biotechnology company that provides drug discovery and development services to pharmaceutical and biotechnology companies. The company combines scientific expertise, technology platforms and specialized laboratories to support the identification, optimization and development of potential medicines.
Its services cover a range of activities, including target discovery, screening, medicinal chemistry, translational research, preclinical development and selected clinical development programs.
Recommended Stories
- Five stocks we like better than Evotec
- MarketBeat Week in Review – 11/2 – 11/6
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
